About Urea Cycle Disorders
Urea cycle disorders (UCDs) are a group of inherited metabolic diseases in which the liver cannot convert ammonia to urea for excretion. The most common form is OTC (ornithine transcarbamylase) deficiency, which is X-linked. Accumulation of ammonia (hyperammonemia) is the central toxic event, causing encephalopathy that can be life-threatening, particularly in neonates. Long-term management includes protein-restricted diet, nitrogen scavenger drugs, and in severe cases liver transplantation.
Common Clinical Features
Clinical Trial Eligibility Tips
What to know before applying to Urea Cycle Disorders trials.
Specify the exact UCD subtype — OTC deficiency trials are separate from citrullinemia or argininosuccinic aciduria trials
Plasma ammonia level and amino acid profile are required baseline biomarkers for most trials
Nitrogen scavenger therapy (sodium benzoate, sodium phenylbutyrate, glycerol phenylbutyrate) use must be documented — some trials require stable dosing
Liver transplantation corrects the metabolic defect — transplanted patients may be ineligible for gene therapy trials
Patient Resources
Find recruiting Urea Cycle Disorders trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Urea Cycle Disorders. Updated daily.